Stay updated on IO102/IO103 Combo + Pembrolizumab in Melanoma Clinical Trial
Sign up to get notified when there's something new on the IO102/IO103 Combo + Pembrolizumab in Melanoma Clinical Trial page.

Latest updates to the IO102/IO103 Combo + Pembrolizumab in Melanoma Clinical Trial page
- Check3 days agoChange DetectedAdded a new 'Results Submission Events' section to the study record history, displaying events related to results submission.SummaryDifference0.1%

- Check10 days agoNo Change Detected
- Check17 days agoNo Change Detected
- Check25 days agoChange DetectedRecord History now includes new data sections (Outcome Measures, Adverse Events, Baseline Characteristics, Participant Flow) and a Quality Control status. It also notes a new revision (Revision: v3.5.0) with the date 2026-03-12.SummaryDifference1.0%

- Check32 days agoChange DetectedAdded revision note for v3.4.3 and removed v3.4.2 from the page's version history.SummaryDifference0.1%

- Check46 days agoChange DetectedStudy history now shows 'Results Submitted' instead of 'No Results Posted', signaling that trial results have been submitted and may be available in the results database.SummaryDifference0.1%

- Check60 days agoChange DetectedRecord history now includes a new entry: Revision: v3.4.2; the previous funding notice and Revision: v3.4.1 have been removed.SummaryDifference0.5%

- Check67 days agoChange DetectedA new site-wide funding-status notice was added and the page revision updated from v3.4.0 to v3.4.1.SummaryDifference0.6%

Stay in the know with updates to IO102/IO103 Combo + Pembrolizumab in Melanoma Clinical Trial
Enter your email address, and we'll notify you when there's something new on the IO102/IO103 Combo + Pembrolizumab in Melanoma Clinical Trial page.